Q Synthesis LLC
  • Home
  • Systems Thinking
  • Implementation Science
  • About
  • Contact
  • Publications
  • Updates

Advances in HER2-positive and HER2-low Breast Cancer

7/30/2020

0 Comments

 
This one-hour interactive, online CME/CMLE module is designed to help pathologists and laboratory professionals gain a deeper scientific understanding of recent advances in the diagnosis and management of HER2-positive and HER2-low breast cancer.
To claim CME credit for this course, please register at https://store.ascp.org/productlisting/productdetail?productId=123811419&_ga=2.269259641.929308495.1598834085-509862140.1542376895

​Supported by an independent educational grant from Daiichi Sankyo, Inc.
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Author

    @DrJosephKim
    Joseph Kim, MD, MPH, MBA, FACEHP is the Founder and President of Q Synthesis LLC.

    ​View Dr. Kim's bio on LinkedIn. 

    ​


    Sign up to receive updates:
Q Synthesis LLC
www.qsynthesis.com
  • Home
  • Systems Thinking
  • Implementation Science
  • About
  • Contact
  • Publications
  • Updates